Tuesday, 8 October 2013

Hope rises for malaria vaccine by 2015

 With the arrival of this vaccine, it is hoped that the billions of dollars spent by developing countries in procuring malaria drugs will be cut down.


The BBC reports that British drug maker GlaxoSmithKline is seeking regulatory approval for the world's first malaria vaccine after trial data showed that it had cut the number of cases in African children.
Experts say that they are optimistic about the possibility of the world's first vaccine after the trial results.
Malaria, a mosquito-borne parasitic disease, kills hundreds of thousands of people worldwide every year.
Scientists say an effective vaccine is key to attempts to eradicate it.
The vaccine known as RTS,S was found to have almost halved the number of malaria cases in young children in the trial and to have reduced by about 25% the number of malaria cases in infants.
GlaxoSmithKline (GSK) is developing RTS,S with the non-profit Path Malaria Vaccine Initiative (MVI), supported by funding from the Bill & Melinda Gates Foundation.
"Many millions of malaria cases fill the wards of our hospitals," said Halidou

No comments:

Post a Comment

Comments made by readers of this blog are strictly the views of the writers and not that of Nedu Echianu's Blog.